Canadian Patented Medicine Prices and Sales Trends, 2024 Annual Report

The 2024 Annual Report from the Patented Medicine Prices Review Board reviews trends in the prices and sales of patented medicines in Canada. It also contains findings on pharmaceutical research and development spending and details the board's price review and reporting activities. The report is published in HTML format under the OGL-CA-2.0 license.

Use Cases

• Analyze price trends for patented medicines in Canada based on the report's review of price data.
• Model pharmaceutical market sales based on the report's sales trend information.
• Assess research and development investment levels in Canada's pharmaceutical sector based on the reported spending findings.
• Understand regulatory oversight activities based on the report's information on price review and reporting.

Strengths

• Report is published by the official Patented Medicine Prices Review Board of Canada, an authoritative source.
• Data covers multiple aspects of the pharmaceutical market including prices, sales, and R&D spending.
• Report was last updated on 2026-04-16, suggesting recent maintenance.

Limitations

• The dataset is presented as an HTML report; the underlying structured data is not directly accessible.
• Row count and specific column-level data are unknown, limiting suitability assessment.
• Description metadata is limited; actual data quality requires manual inspection after download.

Provenance

Source

Patented Medicine Prices Review Board Canada | Conseil d'examen du prix des médicaments brevetés Canada

Collection Method

Likely compiled from regulatory filings and industry reports.

Time Range

Covers the 2024 reporting period.

Freshness

Last updated 2026-04-16 19:26:56.286031; freshness should be verified.

Geography

Canada